Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastics worldwide. The company offers its products for food contact applications and food packaging; medical devices and implants; textiles; pipes and drainages; and anti-fouling and hygiene applications, as well as to prevent mold and material deterioration; and biofilm formation. It holds a patented technology under the Saniconcentrate name. The company was formerly known as Parx Plastics N.V. and changed its name to Parx Materials N.V. in January 2020. Parx Materials N.V. was incorporated in 2012 and is headquartered in Rotterdam, the Netherlands.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
